variable | A group | B group | p value |
---|---|---|---|
(n = 572) No. (%) | (n = 572) No. (%) | ||
Mortality | 8 (1.4) | 14 (2.4) | 0.282 |
MI | 17 (3.0) | 17 (3.0) | 1 |
Stroke | 6 (1.0) | 8 (1.4) | 0.788 |
Respiratory failure | 16 (2.8) | 22 (3.8) | 0.409 |
Pneumonia | 23 (4.0) | 29 (5.1) | 0.478 |
AKI | 62 | 144 | <0.0001 |
Stage I | 54 (9.6) | 113 (20.3) | |
Stage II | 6 (1.1) | 22 (3.9) | |
Stage III | 2 (0.4) | 9 (1.6) | |
Redo for bleeding | 9 (1.6) | 12 (2.1) | 0.66 |
RBC transfusion | 201 (35.1) | 219 (38.3) | 0.622 |
DSWI | 11 (1.9) | 17 (3.0) | 0.339 |
Low cardiac output syndrome | 44 (7.7) | 54 (9.4) | 0.34 |
IABP application | 33 (5.8) | 46 (8.0) | 0.162 |
Lost to follow-up | 18 (3.2) | 20 (3.7) | 0.869 |
Long-term mortality | 21 (3.8) | 37 (6.9) | 0.037 |
CRF requiring dialysis | 0 | 6 (1.1) | 0.039 |